Coverage
-
July 23, 2013
The U.S. Food and Drug Administration on Monday pushed back against Health Science Funding LLC's novel bid for a declaration that labeling on its lupus treatment Prastera complies with FDA requirements for medical foods, arguing that a New Jersey federal court can't step into the agency's shoes and apply its regulations.
1 other articles on this case.
View all »